Asia Deal Watch: Athenex Changes Mind, Gets Back Chinese Rights To Actinic Keratosis Candidate
15 Mar 2019
Acquisition
Following a positive Phase III data readout for KX2-391, Athenex requests dissolution of its recent deal conferring rights to the...
Related Stories Shorter Treatment Time For Chagas Could Blunt Kissing Bug Disease Sandoz Head Francis To Leave Amid Move Towards Autonomy
Vifor Pharma: Targets Acquisitions As Pure-Play Strategy Delivers
Organizations
-Indications
Targets
-Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.